Gabriel Boghossian
Image of Gabriel Boghossian

Gabriel Boghossian

Partner

Gabriel is the co-head of our Band 1 ranked Secondaries practice and has 18 years of experience in the Secondaries sector.

He has extensive experience in structuring and executing the full gamut of Secondaries deals for European clients, from single and multi-asset continuation vehicles, limited partnership portfolio transactions, strip sales, preferred equity and GP stake sales.

Gabriel is ranked Band 1 by Chambers for Secondaries.

Expertise

Industries

Experience

Representative matters

Relevant experience prior to joining A&O Shearman includes advising:
  • Maxburg on its first single-asset continuation vehicle, in excess of EUR500m, led by Accel-KKR.
  • Bid Equity Continuation Fund I. Establishing a USD300m continuation fund, supporting long-term value creation for portfolio companies everii and JustRelate.
  • Greenpeak Continuation Fund I. EUR347m continuation vehicle to maintain investment in Academia and Certania, two strongly performing lab and TIC groups started and built up by GREENPEAK's Fund II.
  • DPE Deutsche Private Equity continuation vehicle establishment. Structuring and launching a EUR708m continuation fund, enabling the firm to retain and grow key assets. Supported Germany’s largest GP-led secondary, helping DPE secure long-term value for investors.
  • Five Arrows Secondary Investments. Eurazeo I-TRACING Continuation Vehicle - Advised TPG and Five Arrows as co-lead investors on their respective commitments to a EUR180m single asset continuation vehicle managed by Eurazeo to support the growth of iTracing.
  • Five Arrows Secondary Investments. LEA Continuation Fund formation - EUR650m formation of a continuation fund, supporting long-term growth strategies.
  • Kline Hill Partners. Acorn Sentry Aerospares CV secondary acquisition – USD350m secondary acquisition, enabling efficient portfolio management and supporting strategic growth in the aviation sector.
  • Kline Hill Partners. PHI Continuation Fund I formation -structuring and launching a EUR212m continuation fund, enabling ongoing investment in high-performing assets.
  • Hayfin. Investcorp Technology HWG CV-Lux secondary investment - EUR240m secondary investment, advancing strategic objectives in the technology sector.
  • Hayfin. Impilo Orphan Drugs AB continuation vehicle investment - EUR320m continuation vehicle, supporting the acquisition of a co-control stake in Immedica Pharma Holding AB.
  • Tesco Pension Trustees Limited (trustee of the Tesco PLC Pension Scheme). Sale of a portfolio of 47 limited partnership interests worth circa USD1bn to six buyer groups.

Leadership Positions And Professional Affiliations

  • Officer, Court of England & Wales

Recognition

“Gabriel is incredibly diligent, knowledgeable and responsive.”
Investment Funds: Private Equity: Secondaries 2026
“Gabriel is one of the most service-oriented lawyers I have met and has an amazing ability to drive negotiations.”
Investment Funds: Private Equity: Secondaries 2026

Awards

  • Band 1 – Investment funds: Private equity: Secondaries. Chambers 2026
  • Band 2, Investment funds: Investor Representation. Chambers 2026
  • Next Generation Partner, Private Funds. Legal 500 UK 2026

Qualifications

Admissions

Solicitor, England & Wales, 2010

Academic

LLB, Law, The University of Edinburgh, 2006

Languages

Armenian, French, Italian
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.